MONTREAL, April 30 /CNW Telbec/ - Sonomax Hearing Healthcare, Inc.
("Sonomax" or the "Company") (TSX Venture: SHH) today disclosed its annual
- Decrease in net revenue to $1,210,614 compared to $2,316,487 in 2007.
- Gross profit was $176,406 in 2008 compared to $819,241 in 2007.
- Raised gross proceeds of $2,020,000 of new equity financing incurring
cash share issue costs of and $217,211 and $475,000 by way of
exercising of warrants by holders thereof.
Full financial statements can be found at: www.sedar.com
Sonomax Hearing Healthcare Inc (TSX Venture:SHH) is a leader in the
development and manufacturing of intra-ear technology for hearing protection,
hearing enhancement, and other auditory applications.
Sonomax has expanded the capability of its SonoPass(R) software so that
it can now test hearing protectors other than SonoCustom(R), with the
objective of establishing individual fit-testing of hearing protectors as the
The Company's SonoPlatform(TM) is the foundation for state-of-the-art
hearing aids, active and passive earpieces for military use, and cellular
telephone and entertainment digital wireless applications.
This news release contains certain forward-looking statements that
reflect the current views and/or expectations of Sonomax Hearing Healthcare
Inc. with respect to its performance, business and future events. Such
statements are subject to a number of risks, uncertainties and assumptions.
Actual results and events may vary significantly.
The TSX Venture Exchange has not reviewed and does not accept
responsibility for the adequacy or accuracy of this release.
For further information:
For further information: Nick Laperle, President, Sonomax Hearing
Healthcare Inc., (514) 932-3745, firstname.lastname@example.org